| Autor: |
Mira Mousa, Mohammed Albreiki, Fatima Alshehhi, Safiya AlShamsi, Nada Al Marzouqi, Tayba Alawadi, Hussain Alrand, Habiba Alsafar, Asma Fikri |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Journal of travel medicine. 29(6) |
| ISSN: |
1708-8305 |
| Popis: |
Inactivated vaccine BBIBP-CorV {Sinopharm; 95% [95% confidence interval (CI): 94, 97%]} and the mRNA vaccine BNT162b2 [Pfizer-BioNTech; 98% (95% CI: 86, 99%)] demonstrated protection against COVID-19 related hospitalizations from the Delta (B.1.617.2) variant. Ongoing efforts are necessary to target vaccine hesitancy and to promote booster shots for protection against severe COVID-19 disease and arising variants of concern. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
